EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hydroxyurea reduces the levels of the fetal globin gene repressors ZBTB7A/LRF and BCL11A in erythroid cells in vitro

Gabriella E Martyn iD, Phillip A Doerfler iD, Yu Yao iD, Kate G R Quinlan iD, Mitchell J Weiss iD, Merlin Crossley iD

Journal of Sickle Cell Disease · 07.11.2024 · 1 (1)

DOI: 10.1093/jscdis/yoae008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Sickle Cell Disease, online erschienen am 03.10.2024. Verfasst von Gabriella E Martyn und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology and Biomolecular Sciences, University of New South Wales (UNSW) Sydney, Sydney, NSW 2052, Australia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Australian National Health and Medical Research Council to M.C.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Hydroxyurea (HU) is the most widely used therapy for adults and children with sickle cell disease (SCD). It is believed to act largely by inducing the transcription of fetal γ-globin genes to generate fetal hemoglobin (HbF), which inhibits the pathological polymerization of sickle hemoglobin (HbS). The mechanisms by which hydroxyurea elevates HbF are unclear. We explored the hypothesis that hydroxyurea induces HbF expression by inhibiting the expression of 2 γ-globin gene repressors, BCL11A and ZBTB7A (also known as LRF), which normally bind the γ-globin gene promoters to inhibit their expression after birth.

Methods

We treated immortalized murine erythroleukemia cells and normal human donor CD34+ hematopoietic stem and progenitor cell-derived erythroblasts with hydroxyurea and measured the effects on globin, BCL11A and ZBTB7A protein and mRNA expression.

Results

Treating murine erythroleukemia cells or human CD34+ hematopoietic stem and progenitor cell-derived erythroblasts with hydroxyurea reduced the protein levels of BCL11A and ZBTB7A compared to the vehicle-treated control. BCL11A mRNA levels were reduced in both cell types upon hydroxyurea treatment. However, ZBTB7A mRNA levels were only reduced in human CD34+ hematopoietic stem and progenitor cell-derived erythroblasts.

Conclusions

Hydroxyurea can act in erythroid cells to reduce the levels and activity of two direct fetal γ-globin transcriptional repressors with accompanying de-repression of the γ-globin genes and induction of HbF, which may explain the mechanism of action leading to amelioration of symptoms in SCD patients treated with this drug.

Schlagwörter

Stichwörter der Autor:innen

BCL11ASCDZBTB7Afetal globinhydroxyurea

Autor:innen und Institutionen

  • School of Biotechnology and Biomolecular Sciences, University of New South Wales (UNSW) Sydney, Sydney, NSW 2052, Australia.
  • Department of Hematology, St Jude Children's Research Hospital, Memphis, TN 38105-3678, United States.

ORCID-Profile: Gabriella E Martyn, Phillip A Doerfler, Yu Yao, Kate G R Quinlan, Mitchell J Weiss, Merlin Crossley

Förderung

  • NIDDK NIH HHS
  • Australian National Health and Medical Research Council to M.C

Zitieren

APA

Martyn, G. E., Doerfler, P. A., Yao, Y., Quinlan, K. G. R., Weiss, M. J., & Crossley, M. (2024). Hydroxyurea reduces the levels of the fetal globin gene repressors ZBTB7A/LRF and BCL11A in erythroid cells in vitro. Journal of Sickle Cell Disease, 1(1). https://doi.org/10.1093/jscdis/yoae008

Vancouver

Martyn GE, Doerfler PA, Yao Y, Quinlan KGR, Weiss MJ, Crossley M. Hydroxyurea reduces the levels of the fetal globin gene repressors ZBTB7A/LRF and BCL11A in erythroid cells in vitro. Journal of Sickle Cell Disease. 2024;1(1). doi:10.1093/jscdis/yoae008

BibTeX
@article{Martyn2024,
  author = {Martyn, Gabriella E and Doerfler, Phillip A and Yao, Yu and Quinlan, Kate G R and Weiss, Mitchell J and Crossley, Merlin},
  title = {Hydroxyurea reduces the levels of the fetal globin gene repressors ZBTB7A/LRF and BCL11A in erythroid cells in vitro},
  journal = {Journal of Sickle Cell Disease},
  year = {2024},
  volume = {1},
  number = {1},
  doi = {10.1093/jscdis/yoae008}
}
Kostenlos starten →